212838-70-5

Basic information

• Product Name: D-(-)-2-CHLOROPHENYLGLYCINE METHYL ESTER HCL
• Synonyms: D-(-)-2-CHLOROPHENYLGLYCINE METHYL ESTER HCL;D-(-)-2-Chlorophenylglycine methyl ester hydrochloride;(R)-Methyl 2-aMino-2-(2-chlorophenyl)acetate hydrochloride;R-2-Chlorophenylglycine methyl ester hydrochloride (1:1)
• CAS NO: 212838-70-5
• Molecular Formula: C9H11Cl2NO2
• Molecular Weight: 236.1
• EINECS: 1308068-626-2
• Mol File: 212838-70-5.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: D-(-)-2-CHLOROPHENYLGLYCINE METHYL ESTER HCL(CAS DataBase Reference)
• NIST Chemistry Reference: D-(-)-2-CHLOROPHENYLGLYCINE METHYL ESTER HCL(212838-70-5)
• EPA Substance Registry System: D-(-)-2-CHLOROPHENYLGLYCINE METHYL ESTER HCL(212838-70-5)

Safety Data

• Hazardous Substances Data: 212838-70-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
D-(-)-2-Chlorophenylglycine methyl ester HCL is used as a research compound for its potential therapeutic properties, particularly in the treatment of schizophrenia, anxiety disorders, and other mental health conditions. Its unique structure allows it to be a valuable tool for scientists and researchers in exploring new avenues for medication development.
Used in Medication Production:
As an important intermediate, D-(-)-2-Chlorophenylglycine methyl ester HCL is used in the synthesis of various pharmaceutical drugs. Its role in the production process is crucial for creating medications that address a range of health issues, making it a vital component in the pharmaceutical industry's efforts to develop new and effective treatments.

Upstream product

• 141109-14-0 methyl (S)-(+)-2-amino-2-(2-chlorophenyl)acetate 
• 86169-24-6 2-amino-(2-chlorophenyl)ethanoic acid 
• 67-56-1 methanol 

Downstream Products

• 1276118-81-0 C₁₆H₁₄ClNO₂ 
• 1446282-66-1 methyl (S)-2-(2-chlorophenyl)-2-(perfluorophenylsulfonamido)acetate 

Relevant articles and documents

Isotopically Directed Symmetry Breaking and Enantioenrichment in Attrition-Enhanced Deracemization

The evolution of homochirality via attrition-enhanced deracemization (AED) of enantiomorphic solids is carried out using molecules that differ only in the isotopic composition of a phenyl group positioned remote from the chiral center. Enantioenrichment c

Preparation method of (S)-chlorophenylglycine methyl ester hydrochloride

The invention discloses a preparation method of (S)-chlorophenylglycine methyl ester hydrochloride. The preparation method comprises the following steps: 1) adding a mixture of o-chlorobenzaldehyde and trimethylsilyl cyanide into a reaction flask, then ad

Discovery of novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as potent HIV-1 inhibitors using a structure-based bioisosterism approach

The present work is an extension of our ongoing efforts towards the development and identification of new molecules with anti-HIV activity which have previously led to the discovery of arylazolylthioacetanilides as highly active NNRTIs. In this article, a series of 2-2-(3-(2-chlorophenyl)pyrazin-2- ylthio)-N-arylacetamide derivatives were synthesized and evaluated for in vitro anti-HIV activity. Most of the tested compounds exhibited moderate activities against wild-type HIV-1. Among them, compound 6k showed significant activity against wild-type HIV-1 with an EC50 value of 1.7 μM, along with moderate activity against wild-type reverse transcriptase (RT). The preliminary structure-activity relationship (SAR) and docking calculations of this new series of compounds were also investigated, which may help designing more potent molecules.

Method for preparing 2-thienylethylamine derivatives

PCT No. PCT/FR98/00441 Sec. 371 Date Sep. 2, 1999 Sec. 102(e) Date Sep. 2, 1999 PCT Filed Mar. 5, 1998 PCT Pub. No. WO98/39322 PCT Pub. Date Sep. 11, 1998The present invention relates to a process for the preparation of 2-thienylethylamine derivatives of general formula: as well as their acid addition salts, in which R represents a halogen atom and R1 represents a C1-C4 alkyl group, characterized in that a thienylglycidic derivative of general formula: in which M represents an alkali metal atom or a fraction of an alkaline-earth metal atom, is reacted with a phenylglycine ester, optionally in the form of a strong acid salt, of general formula: in which R and R1 have the same meaning as above, in the presence of an alkali metal borchydride of general formula: X-YIV in which X represents an alkali metal atom and Y represents a group of formula: -BH3CN or -BH(4-w)Zw in which Z represents a carboxylic acid residue and optionally in the presence of a C1-C4 carboxylic acid, which gives the desired compound in the form of a free base which can be treated, if necessary, with an acid in order to obtain an addition salt of this compound.